TrialEuropean journal of clinical pharmacology2012

Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation.

Yusuke Tanigawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.